Arbutus Biopharma Corp Capital Reinvestment Ratio
Arbutus Biopharma Corp capital reinvestment ratio. Arbutus Biopharma Corp (ABUS) has a Capital Reinvestment Ratio of 0.00x as of March 2022, meaning it reinvests 0% of its operating cash flow ($20.62 Million) in capital expenditures ($75.00K). See how much free cash does Arbutus Biopharma Corp generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Arbutus Biopharma Corp (2012–2012)
Capital reinvestment ratio of Arbutus Biopharma Corp from 2012 to 2012. This chart tracks Arbutus Biopharma Corp's Capital Reinvestment Ratio across 1 annual periods. See how financially flexible is Arbutus Biopharma Corp to measure the company's free cash flow as a share of total liabilities.
Arbutus Biopharma Corp Capital Reinvestment Ratio by Year (2012–2012)
Arbutus Biopharma Corp capital reinvestment ratio by year from 2012 to 2012. For the full cash flow conversion analysis, see Arbutus Biopharma Corp (ABUS) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2012 | 0.00x | $33.27 Million | $14.90K | — |